Elucidating the Role of Electrochemically Formed LiF in Discharge and Aging of Li-CF x Batteries.

Autor: Schoetz T; Department of Chemical Engineering, The City College of New York, CUNY, New York, New York 10031, United States., Robinson LE; Department of Chemical Engineering, The City College of New York, CUNY, New York, New York 10031, United States., Gordon LW; Department of Chemical Engineering, The City College of New York, CUNY, New York, New York 10031, United States., Stariha SA; Jet Propulsion Laboratory, California Institute of Technology, Pasadena, California 91109, United States., Harris CE; Department of Chemical Engineering, The City College of New York, CUNY, New York, New York 10031, United States., Seong HL; Jet Propulsion Laboratory, California Institute of Technology, Pasadena, California 91109, United States., Jones JP; Jet Propulsion Laboratory, California Institute of Technology, Pasadena, California 91109, United States., Brandon EJ; Jet Propulsion Laboratory, California Institute of Technology, Pasadena, California 91109, United States., Messinger RJ; Department of Chemical Engineering, The City College of New York, CUNY, New York, New York 10031, United States.

Publikováno v: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2024 Apr 17; Vol. 16 (15), pp. 18722-18733. Date of Electronic Publication: 2024 Apr 08.

Chronic kidney disease in Asia: Protocol for a collaborative overview.

Autor: Liyanage T; The George Institute for Global Health, School of Medicine, University of Sydney, New South Wales, Australia.; Armadale Kelmscott Memorial Hospital, South Metropolitan Health Service, Perth, Western Australia, Australia., Ninomiya T; The George Institute for Global Health, School of Medicine, University of Sydney, New South Wales, Australia., Perkovic V; The George Institute for Global Health, School of Medicine, University of Sydney, New South Wales, Australia., Woodward M; The George Institute for Global Health, School of Medicine, University of Sydney, New South Wales, Australia., Stirnadel-Farrant H; GlaxoSmithKline, Global Epidemiology, Middlesex, United Kingdom., Matsushita K; Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology Baltimore, USA., Iseki K; Okinawa Heart and Renal Association (OHRA) and Clinical Research Support Center, Tomishiro Central Hospital, Okinawa, Japan., Seong HL; Sultanah Aminah Hospital, Haemodialysis Unit, Johor Bahru, Malaysia., Monaghan H; The George Institute for Global Health, School of Medicine, University of Sydney, New South Wales, Australia., Jha V; The George Institute for Global Health, India, New Delhi, India.; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

Publikováno v: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2017 Jun; Vol. 22 (6), pp. 456-462.

The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.

Autor: Viecelli AK; Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia. andrea.viecelli@health.qld.gov.au., Pascoe E; Australasian Kidney Trials Network, School of Medicine, University of Queensland, Brisbane, QLD, Australia. e.pascoe@uq.edu.au., Polkinghorne KR; Department of Nephrology, Monash Medical Centre, Melbourne, VIC, Australia. kevan.polkinghorne@monash.edu.; Departments of Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. kevan.polkinghorne@monash.edu., Hawley C; Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia. carmel.hawley@health.qld.gov.au.; Australasian Kidney Trials Network, School of Medicine, University of Queensland, Brisbane, QLD, Australia. carmel.hawley@health.qld.gov.au., Paul-Brent PA; Australasian Kidney Trials Network, School of Medicine, University of Queensland, Brisbane, QLD, Australia. p.kerr@uq.edu.au., Badve SV; Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia. sunil.badve@health.qld.gov.au.; Australasian Kidney Trials Network, School of Medicine, University of Queensland, Brisbane, QLD, Australia. sunil.badve@health.qld.gov.au., Cass A; Menzies School of Health Research, Charles Darwin University, Darwin, Australia. alan.cass@menzies.edu.au., Heritier S; Department of Epidemiology, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. Stephane.Heritier@monash.edu., Kerr PG; Department of Nephrology, Monash Medical Centre, Melbourne, VIC, Australia. Peter.Kerr@monash.edu.; Department of Medicine, Monash University, Melbourne, VIC, Australia. Peter.Kerr@monash.edu., Mori TA; School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia. trevor.mori@uwa.edu.au., Robertson A; Department of Surgery, Royal Melbourne Hospital, Melbourne, VIC, Australia. Amanda.Robertson@mh.org.au., Seong HL; Hospital Sultanah Aminah, Johor Bahru, Malaysia. laihooi@pd.jaring.my., Irish AB; School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia. ashley.irish@health.wa.gov.au.; Department of Renal Medicine, Fiona Stanley Hospital, 102-118 Murdoch Drive, Murdoch, WA, 6150, Australia. ashley.irish@health.wa.gov.au.

Publikováno v: BMC nephrology [BMC Nephrol] 2015 Jun 27; Vol. 16, pp. 89. Date of Electronic Publication: 2015 Jun 27.

Trends in drug treatment of benign prostatic hyperplasia in Japan based on the National Database Open Data.

Autor: Sasaki K; Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Suzuki M; Department of Urology, The Kikkoman General Hospital, Noda City, Chiba, Japan., Nakamura M; Department of Urology, NTT Medical Center Tokyo, Tokyo, Japan., Kume H; Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Nishino Y; Department of Urology, Nishino Clinic, Gifu, Japan., Takahashi S; Department of Urology, Nihon University School of Medicine, Tokyo, Japan.

Publikováno v: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Dec; Vol. 31 (12), pp. 1374-1379. Date of Electronic Publication: 2024 Sep 02.

Highly sensitive Au–Fe2O3–Au and Fe2O3–Au–Fe2O3 biosensors utilizing strong surface plasmon resonance.

Autor: Ahmed, Ashour M.¹ (AUTHOR) ashour.elshemey@gmail.com, Shaban, Mohamed¹ (AUTHOR)

Publikováno v: Applied Physics B: Lasers & Optics. Apr2020, Vol. 126 Issue 4, p1-10. 10p. 2 Diagrams, 4 Charts, 4 Graphs.